Drug Shortage Report for GLYCOPYRROLATE INJECTION MULTIDOSE

Last updated on 2020-01-08 History
Report ID 98404
Drug Identification Number 02382849
Brand name GLYCOPYRROLATE INJECTION MULTIDOSE
Common or Proper name Glycopyrrolate Injection Multidose
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) GLYCOPYRROLATE
Strength(s) 0.2MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 1 x 20mL vial / fiole
ATC code A03AB
ATC description DRUGS FOR FUNCTIONAL BOWEL DISORDERS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-24
Estimated end date 2019-12-31
Actual end date 2020-01-03
Shortage status Resolved
Updated date 2020-01-08
Company comments On allocation
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-01-08 French Compare
v3 2020-01-08 English Compare
v2 2019-11-11 French Compare
v1 2019-11-11 English Compare

Showing 1 to 4 of 4